These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1745624

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Parenteral beta-lactamase inhibitor combinations for clinical use.
    Manzella JP.
    Am Fam Physician; 1995 May 15; 51(7):1695-8. PubMed ID: 7754928
    [Abstract] [Full Text] [Related]

  • 5. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC, Barry AL.
    J Reprod Med; 1990 Mar 15; 35(3 Suppl):317-21. PubMed ID: 2319514
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF, Wildfeuer A.
    Arzneimittelforschung; 1990 Oct 15; 40(10):1145-55. PubMed ID: 2291754
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [In vitro activity of ampicillin and ampicillin-sulbactam on diverse bacteria].
    Trucco O, Prado V, Mollinedo E, Cordoves A.
    Rev Med Chil; 1989 Jul 15; 117(7):747-54. PubMed ID: 2519428
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of YTR 830.
    Jacobs MR, Aronoff SC, Appelbaum PC, Yamabe S.
    J Chemother; 1989 Jun 15; 1(3):151-4. PubMed ID: 2552029
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
    Moittie D, Simonet M, Veron M.
    Pathol Biol (Paris); 1989 May 15; 37(5):390-3. PubMed ID: 2789362
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA, Castillo AM, Liébana J, Marín A, Alados JC, Piédrola G.
    J Hyg Epidemiol Microbiol Immunol; 1991 May 15; 35(2):189-97. PubMed ID: 1940333
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.